Latest filing published 16 Jul 2021 for Ovid Therapeutics Inc., €54k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Amit Rakhit: trading record in brief
Amit Rakhit is a declared insider of Ovid Therapeutics Inc. (chief executive), with filings sourced from SEC (Form 4). Altogether 2 filings, all relating to 14 July 2021.
No open-market purchase appears, only 1 sale worth €107k. Other entries cover 1 option exercise.
The latest filing, published on 16 July 2021, reports an open-market sale of €107k in Ovid Therapeutics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amit Rakhit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,017 shares@ US$1.89100.0% of flowCommon StockSEC:0001209191-21-046995:0
1 of 1 declaration
